Your browser doesn't support javascript.
loading
Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China.
Chen, Yihui; Cao, Qiaozhi; Peng, Cong; Zhou, Bingjing; Jiang, Yu; Chen, Xiang; Li, Jie.
Affiliation
  • Chen Y; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Cao Q; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Peng C; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhou B; Furong Laboratory, Changsha, 410008, China.
  • Jiang Y; Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Chen X; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Li J; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
Front Med ; 18(4): 752-756, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39012398

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Front Med / Front. Med. (Online) / Frontiers of Medicine (Online) Year: 2024 Document type: Article Affiliation country: China Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Front Med / Front. Med. (Online) / Frontiers of Medicine (Online) Year: 2024 Document type: Article Affiliation country: China Country of publication: China